![Constantine Chinoporos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Constantine Chinoporos
Director/Board Member at
GERON CORPORATION
Profile
Constantine Chinoporos is currently Director at Halozyme Hypercon, Inc. and will be Director at Geron Corp.
starting in 2026.
Formerly, Mr. Chinoporos was Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021, Chief Business Officer at Albireo Pharma, Inc. from 2021 to 2023, Chief Operating & Business Officer at Applied Therapeutics, Inc. from 2023 to 2026, and Head-Corporate Development at Genzyme Corp.
Education includes an undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Constantine Chinoporos active positions
| Companies | Position | Start |
|---|---|---|
| GERON CORPORATION | Director/Board Member | 25/03/2026 |
Elektrofi, Inc.
 Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Director/Board Member | - |
Former positions of Constantine Chinoporos
| Companies | Position | End |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 03/02/2026 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/03/2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 01/10/2021 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Training of Constantine Chinoporos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
- Stock Market
- Insiders
- Constantine Chinoporos
